Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06724172 · ClinicalTrials.gov registry record · NA
CHIME: Comparing Health Interventions for Maternal Equity
A NA study of Diabetes and Pregnancy, sponsored by Stanford University.
- Recruiting
- Registry status
- NA
- Development phase
- 795
- Enrollment target
- 4
- Study locations
NCT06724172: Recruiting NA study of Diabetes and Pregnancy, sponsored by Stanford University.
NCT06724172 is a NA study of Diabetes and Pregnancy that is actively recruiting participants, run by Stanford University. The registered enrollment target is 795 participants, below the 3,026-participant average among 338 other Diabetes trials with a reported enrollment target (74% lower). The trial reports 4 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06724172, a NA study of Diabetes and Pregnancy, is actively recruiting participants, sponsored by Stanford University.
- RECRUITING
- Registry status
- NA
- Development phase
- 795 participants
- Enrollment target
- 4
- Study locations
Study Summary
The goal of this comparative effectiveness trial is to compare how three different approaches to overcome barriers to resources and provide nutrition and physical activity counseling improve maternal healthy weight in pregnancy and postpartum. The main question it aims to answer is which of the two multi-level, multi-component interventions has greater effectiveness in reducing maternal postpartum weight retention at 12-months postpartum. Hypothesis (primary): Both multi-level, multi-component interventions will have greater effectiveness reducing maternal postpartum weight retention at 12-months postpartum than the usual care group. Hypothesis (secondary): The community-based intervention will have greater effectiveness than the self-management intervention. Participants will be asked to participate in one of the study interventions from early pregnancy until 12 months postpartum and complete five research visits. General procedures include completion of: * Questionnaires * Dietary recalls * In-depth interviews * Anthropometric measurements * Collection of blood via finger stick or blood panel
Primary Outcome
The primary outcome will be calculated as the difference between baseline weight and 12-month postpartum weight. Baseline weight will be defined as the first clinical measure of maternal weight prior to 12 weeks gestation.
Conditions Studied
Interventions
- BEHAVIORAL Self-Management
- BEHAVIORAL Community-Based
Study Locations (4)
New York
- New York Presbyterian Queens - Flushing
- Columbia University Medical Center - New York
- NYU Langone Health - New York
California
- Stanford University - Palo Alto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 795 participants |
| Start Date | 2026-01-22 |
| Est. Completion | 2030-04-01 |
| Phase | NA |
What NCT06724172 shows while recruiting
NCT06724172 is an interventional study that assigns participants to a tested intervention. The registered 795 participants enrollment target is mid-sized for trials with a published cap, below the 3,026-participant average among 338 other Diabetes trials with a reported enrollment target (74% lower).
The record links to 5 conditions, with Diabetes appearing as the primary indexed condition, and to 2 interventions - of which Self-Management is the first listed.
NCT06724172 reports a single indexed study location in New York, California.
Frequently Asked Questions
What is clinical trial NCT06724172 about?
NCT06724172 is a clinical study titled "CHIME: Comparing Health Interventions for Maternal Equity". The goal of this comparative effectiveness trial is to compare how three different approaches to overcome barriers to resources and provide nutrition and physical activity counseling improve maternal healthy weight in pregnancy and postpartum. The main question it aims to answer is which of the two...
What is the current status of trial NCT06724172?
This trial is currently recruiting. It is a NA study. The enrollment target is 795 participants. The study started on 2026-01-22. Estimated completion is 2030-04-01.
What conditions does trial NCT06724172 study?
This clinical trial studies the following conditions: Diabetes, Pregnancy, Chronic Disease, Obesity and Overweight, Nutrition.
What interventions are being tested in trial NCT06724172?
The interventions under investigation include: Self-Management (BEHAVIORAL), Community-Based (BEHAVIORAL).
Who is sponsoring clinical trial NCT06724172?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06724172 being conducted?
This trial has 4 study locations across California, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06724172's enrollment target sits among peer trials
795 54th of 338 higher than 285 of 338 other Diabetes trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effect of 2-Week Continuous Glucose Monitoring on Glycemic Management in Patients New-to-Insulin on Hospital Discharge
RECRUITING · NA
-
Effects of Whole vs. Nonfat Milk Consumption on Body Composition in Children
RECRUITING · NA
-
Efficacy of Viome's Precision Nutrition Program Towards Reducing HbA1c
RECRUITING · NA
-
Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial
RECRUITING · NA
-
Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial
RECRUITING · NA
-
Bringing Advocacy Via Digital Guide to the Emergency Department (Project BADGE)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06208150 · 795 participants · Phase 3
A Study Comparing Talquetamab Plus Pomalidomide, Talquetamab Plus Teclistamab, and Elotuzumab, Pomalidomide, and Dexamethasone or Pomalidomide, Bortezomib, and Dexamethasone in Participants With Relapsed or Refractory Myeloma Who Have Received an Anti-CD38 Antibody and Lenalidomide
- NCT05150691 · 796 participants · Phase 1
A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors
- NCT03424005 · 792 participants · Phase 1
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer
- NCT05866081 · 792 participants · NA
Stent Omission After Ureteroscopy and Lithotripsy in the Michigan Urological Surgery Improvement Collaborative
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI